EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment

Víctor Marín, Viviana Burgos, Rebeca Pérez, Durvanei Augusto Maria, Paulo Pardi, Cristian Paz iD

International Journal of Molecular Sciences · 27.06.2023 · 24 (13) · 10737

DOI: 10.3390/ijms241310737 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.06.2023. Verfasst von Víctor Marín und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Natural Products & Drug Discovery, Center CEBIM, Department of Basic Sciences, Faculty of Medicine, Universidad de La Frontera, Temuco …. Hauptthemen laut MEDLINE: Breast Neoplasms, Catechin. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is one of the most diagnosed cancers worldwide, with an incidence of 47.8%. Its treatment includes surgery, radiotherapy, chemotherapy, and antibodies giving a mortality of 13.6%. Breast tumor development is driven by a variety of signaling pathways with high heterogeneity of surface receptors, which makes treatment difficult. Epigallocatechin-3-gallate (EGCG) is a natural polyphenol isolated as the main component in green tea; it has shown multiple beneficial effects in breast cancer, controlling proliferation, invasion, apoptosis, inflammation, and demethylation of DNA. These properties were proved in vitro and in vivo together with synergistic effects in combination with traditional chemotherapy, increasing the effectiveness of the treatment. This review focuses on the effects of EGCG on the functional capabilities acquired by breast tumor cells during its multistep development, the molecular and signal pathways involved, the synergistic effects in combination with current drugs, and how nanomaterials can improve its bioavailability on breast cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsCatechinHumansFemalePolyphenolsBreastSignal TransductionApoptosisTea

Stichwörter der Autor:innen

breast cancerdrug deliveryepigallocatechin-3-gallatemetabolismsynergistic chemotherapy

Substanzen

epigallocatechin gallateCatechinPolyphenolsTea

Autor:innen und Institutionen

  • Laboratory of Natural Products & Drug Discovery, Center CEBIM, Department of Basic Sciences, Faculty of Medicine, Universidad de La Frontera, Temuco 4780000, Chile.
  • Departamento de Ciencias Biológicas y Químicas, Facultad de Recursos Naturales, Universidad Católica de Temuco, Rudecindo Ortega, Temuco 02950, Chile.
  • Departamento de Ciencias Básicas, Facultad de Ciencias, Universidad Santo Tomas, Temuco 4780000, Chile.
  • Development and Innovation Laboratory, Butantan Institute, Sao Paulo 1500, Brazil.
  • Nucleo de Pesquisas NUPE/ENIAC University Center, Guarulhos 07012-030, Brazil.

ORCID-Profile: Cristian Paz

Zitieren

APA

Marín, V., Burgos, V., Pérez, R., Maria, D. A., Pardi, P., & Paz, C. (2023). The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment. International Journal of Molecular Sciences, 24(13), 10737. https://doi.org/10.3390/ijms241310737

Vancouver

Marín V, Burgos V, Pérez R, Maria DA, Pardi P, Paz C. The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment. International Journal of Molecular Sciences. 2023;24(13):10737. doi:10.3390/ijms241310737

BibTeX
@article{Marn2023,
  author = {Marín, Víctor and Burgos, Viviana and Pérez, Rebeca and Maria, Durvanei Augusto and Pardi, Paulo and Paz, Cristian},
  title = {The Potential Role of Epigallocatechin-3-Gallate (EGCG) in Breast Cancer Treatment},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {13},
  pages = {10737},
  doi = {10.3390/ijms241310737}
}
Kostenlos starten →